So there has been much discussion about the technical reasons. What this comes down to, the reason for the legislative change today, is ultimately that the Medicines Act 1981 is out of date, has been unable to keep up with rapid advances in technology and medicines, and it's actually something that, when I was health spokesperson for the Green Party, was constantly raised with me by people who had different forms of cancer. They weren't able to access some of the most cutting-edge treatments because our process for approving medicines is actually very, very slow and doesn't allow for that widespread, rapid uptake of something. So it is important. This is a quick fix to that. It's not the long-term fix, which is to move to the Therapeutic Products Bill, which I know has been a complicated piece of work that has taken a long time, especially given that we had to face the pandemic.